WEDNESDAY, Dec. 22, 2021 (HealthDay News) The U.S. Army says it has developed a COVID-19 vaccine it believes could work against any and all coronavirus variants, including omicron. Results
The week s good news: December 23, 2021 theweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theweek.com Daily Mail and Mail on Sunday newspapers.
The Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine developed by researchers at the Walter Reed Army Institute of Research (WRAIR) not only elicits a potent immune response but may also provide broad protection against SARS-CoV-2 variants of concern as well as other coronaviruses, according to a series of recently published preclinical study.